Futong Technology Development Holdings Limited (0465.HK)

Negative revenue growth while 8198.HK stands at 31.47%. Joel Greenblatt would look for strategic missteps or cyclical reasons.

Negative gross profit growth while 8198.HK is at 117.84%. Joel Greenblatt would examine cost competitiveness or demand decline.

No Data available this quarter, please select a different quarter.

Negative operating income growth while 8198.HK is at 35.77%. Joel Greenblatt would press for urgent turnaround measures.

Negative net income growth while 8198.HK stands at 16.44%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.

Negative EPS growth while 8198.HK is at 27.65%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while 8198.HK is at 27.65%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

No Data available this quarter, please select a different quarter.

Negative OCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.

Negative FCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.

Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.

Negative 5Y CAGR while 8198.HK stands at 210.25%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Negative 3Y CAGR while 8198.HK stands at 2143.36%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

Negative 10Y OCF/share CAGR while 8198.HK stands at 138.21%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.

Below 50% of 8198.HK's 1933.67%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.

Negative 3Y OCF/share CAGR while 8198.HK stands at 177.82%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.

Negative 10Y net income/share CAGR while 8198.HK is at 92.13%. Joel Greenblatt sees a major red flag in long-term profit erosion.

Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.

Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.

Below 50% of 8198.HK's 117.01%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.

Cut dividends over 10 years while 8198.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.

Negative 5Y dividend/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.

No Data available this quarter, please select a different quarter.

Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.

Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.

Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.

We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.

We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.

Our R&D shrinks while 8198.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.